Dim Light at Night in Patients With Obstructive Sleep Apnea

Status Withdrawn

Clinical Trial Summary

With the advent of electricity, light at night has become a ubiquitous part of our society.

The main purpose of this study is to determine whether sleeping with dim light (40 lux), the brightness of a night light) in your bedroom for 5 consecutive nights will result in increased markers of inflammation in the blood compared to sleeping in darkness during the night in patients with obstructive sleep apnea (OSA).

A secondary aim is to examine the effects on insulin sensitivity, other blood proteins, and RNA molecules as a result of sleeping with dim light. RNA molecules are substances in blood that dictate what type of proteins the body should make.

Clinical Trial Description

The primary objective of this study is to determine whether sleeping with dLAN (40 lux) for 5 consecutive nights will result in increased markers of inflammation compared to sleeping in darkness (< 1 lux) during the night in patients with OSA. A secondary aim is to examine the effects on insulin sensitivity, adipokines, and RNA molecules.

The risks associated with this study are minimal compared to the potential benefits. Knowledge about the effects of sleeping with dim light on inflammation in patients with OSA is important and would guide future recommendations about proper sleep hygiene. This research may also guide future recommendations about light conditions in other environments such as hospital bedrooms. ;

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor)

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01853891
Study type	Interventional
Source	Ohio State University
Contact
Status	Withdrawn
Phase	N/A
Start date	February 2013

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04939168` - Measuring Atomoxetine and Aroxybutynin In Patients With OSA	Phase 2
Completed	`NCT02908529` - Atomoxetine and Oxybutynin in Obstructive Sleep Apnea	Phase 1/Phase 2
Completed	`NCT03415633` - Validity of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea	N/A
Completed	`NCT03426631` - DAW1033B2 in Obstructive Sleep Apnea	Phase 1/Phase 2
Completed	`NCT04206449` - Sleep Thermography for Diagnosis of Obstructive Sleep Apnea (TERMOAPNEA)	N/A
Active, not recruiting	`NCT03018912` - Validating the Use of a Subjectively Reported Sleep Vital Sign	N/A
Completed	`NCT02549508` - Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD	N/A
Completed	`NCT01249924` - The Effectiveness of Perioperative CPAP to Reduce Obstructive Sleep Apnea Related Adverse Events	N/A
Completed	`NCT00773721` - Foam Mask - Assessment of Bioburden in a New Mask Seal Material	N/A
Completed	`NCT02314858` - Tailored Treatment to Enhance Risk Perception in Sleep Apnea	N/A
Completed	`NCT01476917` - The ATLAST Long-Term Study	Phase 2/Phase 3
Terminated	`NCT00730041` - Palatal Implants in Combination With Continuous Positive Airway Pressure to Treat Obstructive Sleep Apnea	Phase 4
Completed	`NCT00850434` - Improved Automatic CPAP Algorithm to Treat Obstructive Sleep Apnea (OSA)	N/A
Enrolling by invitation	`NCT04538755` - DAW2020 on OSA Endotypic Traits	Phase 1/Phase 2
Completed	`NCT02501304` - Feasibility Study of the ReVENT Sleep Apnea System	N/A
Withdrawn	`NCT02805777` - Vent Flow Study of Prototype Nasal CPAP Mask	N/A
Completed	`NCT02097212` - Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea	N/A
Active, not recruiting	`NCT02295306` - Overnight Polysomnography and Respiratory Volume Monitor
Terminated	`NCT01877928` - Post-extubation Boussignac CPAP System in Adults With Moderate to Severe Obstructive Sleep Apnea	N/A
Completed	`NCT01939938` - Pilot Study of the Comparison of the Upper Airway Dynamics of Oronasal vs Nasal Masks With PAP Treatment	N/A